N/A
Completed N=46
Hair Care Product Use Among Women Of Color
Breast Cancer · Pregnancy Related · Exposure During Pregnancy
Source: ClinicalTrials.gov NCT04493892 ↗
Enrolled (actual)
46
Serious AEs
0.0%
Results posted
May 2024
Primary outcomePrimary: Change in Internal Dose of Urinary Phthalate Metabolites — 1.9 percent change of sumLMW
Summary
The purpose of this study is to reduce use of personal care products that contain endocrine disrupting chemicals among women. For this pilot intervention, the investigators focus on the hair care product class of personal care products, the reduction in use of phthalate-containing Hair Care Products (HCPs) and use among pregnant Women of Color (WOC).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Internal Dose of Urinary Phthalate Metabolites |
-16.5 | — |
| SECONDARY Number of Participants With a Change in PAPM Stage |
5 | — |
Eligibility Criteria
Inclusion Criteria
- English and/or Spanish Speaking
- Pregnant women within first 4 weeks of 3rd trimester of pregnancy
- Lives within Northern Manhattan
- Women of color defined as Black or Hispanic women
Exclusion Criteria
- Does not provide consent
Data sourced from ClinicalTrials.gov (NCT04493892). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.